GUJARAT INJECT (KERALA) LTD. (GUJINJEC.BO)
INR 19.41
(-7.48%)
INR 19.41
(-7.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.05 Million INR | 90.48% |
| 2022 | 554.9 Thousand INR | 1781.16% |
| 2021 | 29.49 Thousand INR | 102.8% |
| 2020 | -1.05 Million INR | -47940.18% |
| 2019 | 2200.00 INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.65 Million INR | 264.03% |
| 2023 Q1 | 372 Thousand INR | 354.19% |
| 2023 FY | - INR | 90.48% |
| 2023 Q4 | 459 Thousand INR | 652.46% |
| 2023 Q3 | 61 Thousand INR | -63.25% |
| 2023 Q2 | 166 Thousand INR | -55.38% |
| 2022 Q4 | 81.9 Thousand INR | 148.19% |
| 2022 Q1 | 72 Thousand INR | 71.43% |
| 2022 Q3 | 33 Thousand INR | -91.03% |
| 2022 FY | - INR | 1781.16% |
| 2022 Q2 | 368 Thousand INR | 411.11% |
| 2021 Q3 | -2000.00 INR | 0.0% |
| 2021 FY | - INR | 102.8% |
| 2021 Q1 | -3000.00 INR | -104.84% |
| 2021 Q4 | 42 Thousand INR | 2200.0% |
| 2020 Q1 | 4000.00 INR | 0.0% |
| 2020 Q4 | 62 Thousand INR | 212.73% |
| 2020 Q3 | -55 Thousand INR | 0.0% |
| 2020 FY | - INR | -47940.18% |
| 2019 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 36.55 Million INR | 97.121% |
| Checkpoint Trends Limited | 297.07 Thousand INR | -254.337% |
| Everest Organics Limited | 118.72 Million INR | 99.113% |
| NATURO INDIABULL LIMITED | 14.68 Million INR | 92.833% |
| NEXUS SURGICAL AND MEDICARE LI | 2.98 Million INR | 64.7% |
| Rajnish Wellness Limited | 19.93 Million INR | 94.721% |
| Rama Vision Limited | 67.79 Million INR | 98.447% |
| Vivo Bio Tech Limited | 212.99 Million INR | 99.506% |